FDA approves Brineura for type of Batten disease - Healio

FDA approves Brineura for type of Batten disease Healio The FDA has approved cerliponase alfa to curb the loss of ambulation among patients aged 3 years and older diagnosed with late infantile neuronal ceroid lipofuscinosis type 2, an extremely rare and fatal autosomal recessive neurodegenerative disorder, ... and more »

from Health - Google News http://ift.tt/2qgsFpE